A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
Clinical trial NCT05342636 · COMPLETED
Trial details
- NCT number
- NCT05342636
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2025-12-05
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.